SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Baxter Announces FDA De Novo Authorization for Theranova Dialyzers Enabling HDx Therapy

U.S. patients with kidney failure now have access to expanded hemodialysis (HDx) therapy delivered by Theranova, a new class of dialyzer Theranova dialyzer's unique membrane design offers a

 · 
  • U.S. patients with kidney failure now have access to expanded hemodialysis (HDx) therapy delivered by Theranova, a new class of dialyzer
  • Theranova dialyzer's unique membrane design offers a filtration profile that more closely mimics that of the natural kidney and can be used with existing hemodialysis machines1,2
  • Theranova was reviewed by FDA through the De Novo process, a pathway for novel low- to moderate-risk devices